Covid-19, the anti-vaccine movement and immunization challenges in Brazil
AIMS: The COVID-19 pandemic suddenly and significantly increased hospitalizations for pneumonia with systemic inflammatory disease. Since its appearance, COVID-19 has affected more than 200 countries, with more than 90 million cases and almost 2 million deaths. So far, there is no quality evidence regarding the specific pharmacological therapy for COVID-19; most treatments usually involve off-label use of existing drugs and have unproven efficacy. The global effort converges on the development of a vaccine; however, the greatest challenge is to achieve collective immunization in the face of increasing vaccination hesitancy.
METHODS: This study investigated the impact of vaccine hesitancy movements on the goal of COVID-19 immunization in Brazil. An integrative bibliographic review was performed with an electronic search on PubMed and SciELO that yielded 13.535 articles. Inclusion and exclusion criteria were applied which included 29 interventional and descriptive studies.
RESULTS: The results of the 29 studies revealed that the most frequent reasons for hesitation is skepticism about the true interests of the industry and politicians, the lack of trust in research, and inaccurate information on social media.
CONCLUSION: The main factors that lead the population not to believe in vaccines were the real interests of industry and politicians, lack of confidence in research, and the amount of false information that circulates massively on social media and because of that it is possible that Brazil will face some challenges in achieving collective immunity due to the anti-vaccine movement.
Chen J. Pathogenicity and transmissibility of 2019-nCoV-A quick overview and comparison with other emerging viruses. Microbes Infect. 2020;22(2):69-71. https://doi.org/10.1016/j.micinf.2020.01.004
Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review. JAMA. 2020;324(8)782-93. http://jamanetwork.com/article.aspx?doi=10.1001/jama.2020.12839
Huang H, Zhang M, Chen C, Zhang H, Wei Y, Tian J, et al. Clinical Characteristics of COVID-19 in patients with pre-existing ILD: A retrospective study in a single center in Wuhan, China. J Med Virol. 2020;92:2742-50. https://doi.org/10.1002/jmv.26174
Tang JW, Tambyah PA, Hui DSC. Emergence of a novel coronavirus causing respiratory illness from Wuhan, China. J Infect. 2020;80(3):350-71. DOI: https://doi.org/10.1016/j.jinf.2020.01.014
Habibzadeh P, Stoneman EK. The Novel Coronavirus: A Bird’s Eye View. Int J Occup Environ Med. 2020;11(2):65-71. https://doi.org/10.15171/ijoem.2020.1921
Beutels P, Van Doorslaer E, Van Damme P, Hall J. Methodological issues and new developments in the economic evaluation of vaccines. Expert Rev Vaccines. 2003;2(5):649-60. https://doi.org/10.1586/14760522.214.171.1249
Brown AL, Sperandio M, Turssi CP, Leite RMA, Berton VF, Succi RM, et al. Vaccine confidence and hesitancy in Brazil. Cad Saude Publica. 2018;34(9):e00011618. https://doi.org/10.1590/0102-311x00011618
Succi RCM. Vaccine refusal - what we need to know. J Pediatr (Rio J). 2018;94(6):574-81. https://doi.org/10.1016/j.jped.2018.01.008
Gidengil CA, Parker AM, Zikmund-Fisher BJ. Trends in risk perceptions and vaccination intentions: a longitudinal study of the first year of the H1N1 pandemic. Am J Public Health. 2012;102(4):672-9. https://doi.org/10.2105/AJPH.2011.300407
Salathé M, Bonhoeffer S. The effect of opinion clustering on disease outbreaks. J R Soc Interface. 2008;5(29):1505-8. https://doi.org/10.1098/rsif.2008.0271
Schaefer GO, Tam CC, Savulescu J, Voo TC. COVID-19 vaccine development: Time to consider SARS-CoV-2 challenge studies? Vaccine. 2020;38(33):5085-8. https://doi.org/10.1016/j.vaccine.2020.06.007
Patel SK, Pathak M, Tiwari R, Yatoo MI, Malik YS, Sah R, et al. A vaccine is not too far for COVID-19. J Infect Dev Ctries. 2020;14(5):450-3. https://doi.org/10.3855/jidc.12744
Mahase E. Covid-19: What do we know so far about a vaccine? BMJ. 2020;369:m1679. https://doi.org/10.1136/bmj.m1679
Mahase E. Covid-19: Oxford team begins vaccine trials in Brazil and South Africa to determine efficacy. BMJ. 2020;369:m2612. https://doi.org/10.1136/bmj.m2612
Khan YH, Mallhi TH, Alotaibi NH, Alzarea AI, Alanazi AS, Tanveer N, et al. Threat of COVID-19 Vaccine Hesitancy in Pakistan: The Need for Measures to Neutralize Misleading Narratives. Am J Trop Med Hyg. 2020;103(2):603-4. https://doi.org/10.4269/ajtmh.20-0654
Iserson KV. SARS-CoV-2 (COVID-19) Vaccine Development and Production: An Ethical Way Forward. Camb Q Healthc Ethics. 2020(1):59-68. https://doi.org/10.1017/S096318012000047X
Fadda M, Albanese E, Suggs LS. When a COVID-19 vaccine is ready, will we all be ready for it? Int J Public Health. 2020;65:711-2. https://doi.org/10.1007/s00038-020-01404-4
Hussain A, Ali S, Ahmed M, Hussain S. The Anti-vaccination movement: a regression in modern medicine. Cureus. 2018;10(7):e2919. doi: 10.7759/cureus.2919
Isaacs D. Vaccine hesitancy and anti-vaccination movements. J Paediatr Child Health. 2019;55(11):1293-4. https://doi.org/10.1111/jpc.14581
Johnson NF, Velásquez N, Restrepo NJ, Leahy R, Gabriel N, El Oud S, et al. The online competition between pro- and anti-vaccination views. Nature. 2020;582(7811):230-3. https://doi.org/10.1038/s41586-020-2281-1
Megget K. Even covid-19 can’t kill the anti-vaccination movement. BMJ. 2020;369:m2184. https://doi.org/10.1136/bmj.m2184
Jolley D, Douglas KM. The effects of anti-vaccine conspiracy theories on vaccination intentions. PLoS One. 2014;9(2):e89177. https://doi.org/10.1371/journal.pone.0089177
Hardt K, Schmidt-Ott R, Glismann S, Adegbola RA, Meurice FP. Sustaining Vaccine Confidence in the 21st Century. Vaccines (Basel). 2013;1(3):204-24. https://doi.org/10.3390/vaccines1030204
Larson HJ, Schulz WS, Tucker JD, Smith DM. Measuring vaccine confidence: introducing a global vaccine confidence index. PLoS Curr. 2015;7:ecurrents.outbreaks.ce0f6177bc97332602a8e3fe7d7f7cc4. https://doi.org/10.1371/currents.outbreaks.ce0f6177bc97332602a8e3fe7d7f7cc4
Stein RA. The golden age of anti-vaccine conspiracies. Germs. 2017;7(4):168-70. https://doi.org/10.18683/germs.2017.1122
Mendonça ReC, de Araújo TM. Analysis of scientific production on the usage of contraceptive methods by adolescents. Rev Bras Enferm. 2010;63(6):1040-5. https://doi.org/10.1590/S0034-71672010000600026
Barbieri M, Capri S, Waure C, Boccalini S, Panatto D. Age- and risk-related appropriateness of the use of available influenza vaccines in the Italian elderly population is advantageous: results from a budget impact analysis. J Prev Med Hyg. 2017;58(4):E279-87. https://doi.org/10.15167/2421-4248/jpmh2017.58.4.867
Ball P. Anti-vaccine movement could undermine efforts to end coronavirus pandemic, researchers warn. Nature. 2020;581(7808):251. https://doi.org/10.1038/d41586-020-01423-4
Badur S, Ota M, Öztürk S, Adegbola R, Dutta A. Vaccine confidence: the keys to restoring trust. Hum Vaccin Immunother. 2020;16(5):1007-17. https://doi.org/10.1080/21645515.2020.1740559
Harrison EA, Wu JW. Vaccine confidence in the time of COVID-19. Eur J Epidemiol. 2020;35(4):325-30. https://doi.org/10.1007/s10654-020-00634-3
Copyright (c) 2021 Scientia Medica
This work is licensed under a Creative Commons Attribution 4.0 International License.
The submission of originals to Scientia Medica implies the transfer by the authors of the right for publication. Authors retain copyright and grant the journal right of first publication. If the authors wish to include the same data into another publication, they must cite Scientia Medica as the site of original publication.
Creative Commons License
Except where otherwise specified, material published in this journal is licensed under a Creative Commons Attribution 4.0 International license, which allows unrestricted use, distribution and reproduction in any medium, provided the original publication is correctly cited.